12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

LR769 hematology data

An international trial in patients with congenital hemophilia A or B showed that 2 doses of 25, 75 or 225 µg/kg LR769 were well tolerated with no...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >